findmyKOL
Clinical trialNCT01529411CompletedPhase 2Interventional

Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial Cancer

SponsorSpanish Oncology Genito-Urinary GroupEnrollment86Carcinoma, Transitional Cell
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Spain
  • Hospital General de Elda Virgen de la Salud

    Elda, Alicante, Spain

  • Ico-Hospital Universitari Germans Trias I Pujol

    Badalona, Barcelona, Spain

  • Ico-Hospital Duran I Reynals

    L'Hospitalet de Llobregat, Barcelona, Spain

  • Hospital Fundació Althaia

    Manresa, Barcelona, Spain

  • Corporació Sanitaria Parc Taulí

    Sabadell, Barcelona, Spain

  • Complejo Hosp. Univ. de Santiago de Compostela

    Santiago de Compostela, Galicia, Spain

  • Hospital Universitario Fundación Alcorcón

    Alcorcón, Madrid, Spain

  • H. Universitari Vall D'Hebrón

    Barcelona, Spain

  • H. del Mar (fundació Institut Mar D´investigacions Mèdiques - Fimim)

    Barcelona, Spain

  • Hospital Clínic I Provincial de Barcelona

    Barcelona, Spain

  • H. General Universitario de Ciudad Real

    Ciudad Real, Spain

  • Hospital Clínico San Carlos

    Madrid, Spain

  • Hospital General Universitario Gregorio Marañon

    Madrid, Spain

  • Hospital Universitario 12 de Octubre

    Madrid, Spain

  • Hospital Universitari Son Espases

    Palma de Mallorca, Spain

  • Clínica Universitaria de Navarra (cun)

    Pamplona, Spain

  • Complejo Hospitalario de Navarra

    Pamplona, Spain

  • H. Universitario Virgen de la Macarena

    Seville, Spain

  • H. Universitario Virgen del Rocío

    Seville, Spain

  • Ivo

    Valencia, Spain

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-((2R,4R,6S,8S)-4-(1,1-difluoroethyl)-1,3,4,5,6,7,8,9-octahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino(4,3-b)indol-8-yl)-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2beta,3beta,4beta,5alpha,12R,19alpha)- →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Feb 2012
Primary completion
28 Feb 2013
Completion
31 Dec 2014
Last update posted
4 Apr 2019
Registered enrollment
86
Registry id
NCT01529411
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.